Pressure BioSciences Announces Agreement with Somalab SOUTH EASTON, MA / ACCESSWIRE / July 5, 2023 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBIO" or the "Company"), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide nutraceuticals, cosmeceuticals, biotherapeutics, food and beverage, and other industries, and Somalab International LLC ("Somalab"), a Texas-based leading supplier of novel health and wellness products throughout the U.S., today announced the execution of an agreement (the "Agreement") for the collaborative development and distribution of UltraShear™ Technology (UltraShear™)-enhanced health and wellness products.
Under the Agreement, the companies will (i) use the UltraShear platform to increase the already high quality of existing Somalab products to even higher, next-generation levels; and (ii) collaborate to develop new products that offer this same next-generation level of quality, including an enhanced "Brain Boost" product. Somalab will also immediately begin distribution of PBIO's best-in-class, preservative-free, 100% plant-based, and highly bioavailable Nano-CBD topical spray.
Mr. Earl Green, CEO and Founder of Somalab, commented: "In our never-ending pursuit of excellence, we recently discovered PBIO and their UltraShear technology. We quickly learned how and why their patented UltraShear platform delivers the best-in-class nanoemulsification solution available worldwide. We are thrilled to begin the announced collaboration, which will include enhancements to several of our products that already provide leading quality performance levels, as well as the introduction of their unique Nano-CBD topical spray to the thousands of customers in our data base."
Mr. Green continued: "We are also very excited about collaborating with PBIO on the development of a next-generation Brain Boost product. Our current Brain Boost Caps are one of our best sellers. But even a "best seller' can be enhanced, which we fully expect from the nanoemulsions resulting from UltraShear processing. Brain health is very important, but it can be hard to recover and/or maintain as we grow older. Fortunately for our customers, we believe that UltraShear processed nanoemulsions will enhance our already powerful and effective Brain Boost products."
Mr. Richard T. Schumacher, PBIO's President and CEO, commented: "This is a tremendous opportunity for both companies. Somalab benefits with immediate sales from PBIO's preservative-free, all plant-based, highly bioavailable, and best-in-class Nano-CBD topical spray. PBIO benefits from significant incremental revenues expected from these sales. Both companies benefit by incorporating UltraShear processing into Somalab's existing and future product line."
Mr. Schumacher added: "We believe Somalab's sale of our Nano-CBD will add over $200,000 in revenue for PBIO in 2023 and more than $1,000,000 in 2024. As exciting as that forecast is, we believe sales of an UltraShear-based, next-generation Brain Boost product could easily eclipse sales of Nano-CBD during 2024 - and Somalab is already suggesting additional products that could exceed our forecast for the UltraShear-enhanced next-generation Brain Boost product."
Mr. Schumacher concluded: "In addition to announcing this very exciting and profitable partnership with Somalab, we have also recently closed on several additional business transactions that will be announced in the coming days - transactions that we believe will also have significant impacts on our sales and growth during the second half of 2023, and beyond."
https://www.accesswire.com/765651/Pressure-BioSciences-Announces-Agreement-with-Somalab-Intl-for-Development-Distribution-of-UltraShear-Enabled-Nanoemulsified-Health-and-Wellness-Products